This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
All You Need to Know About Smucker (SJM) Rating Upgrade to Buy
by Zacks Equity Research
Smucker (SJM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SJM vs. MDLZ: Which Stock Is the Better Value Option?
by Zacks Equity Research
SJM vs. MDLZ: Which Stock Is the Better Value Option?
Can Clorox (CLX) Rebound on Pricing & Cost-Saving Efforts?
by Zacks Equity Research
Solid demand, pricing actions, cost-saving efforts and other growth strategies are likely to aid Clorox's (CLX) performance in the near future.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is Smucker (SJM) Down 12.8% Since Last Earnings Report?
by Zacks Equity Research
Smucker (SJM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
J.M. Smucker's (SJM) Sale of Sahale Snacks to Refine Portfolio
by Zacks Equity Research
The J.M. Smucker (SJM) will offload its Sahale Snacks brand to Second Nature Brands to focus on areas with greater potential.
M&A Activity: Down but Still Alive
by Derek Lewis
Merger and acquisition (M&A) activity has slowed, with lingering uncertainty weighing on potential deals. However, it's not entirely dead.
Growth Efforts to Aid Constellation Brands (STZ) Amid High Costs
by Zacks Equity Research
Constellation Brands (STZ) looks well-poised for growth on a solid beer unit, strong demand and its premiumization strategy. However, higher packaging and raw material costs are woes.
The J.M. Smucker's (SJM) Solid Pricing Aids Amid Cost Woes
by Zacks Equity Research
The J.M. Smucker (SJM) gains on efficient pricing amid cost inflation. A focus on core priorities and categories like coffee, snacking and pet are working well.
Keurig Dr Pepper (KDP) Cheers Investors With Dividend Hike
by Zacks Equity Research
Amid the rising cost concerns, Keurig Dr Pepper (KDP) rewards its shareholders with a dividend payment of 86 cents per share, payable on Oct 13, 2022.
AB InBev (BUD) on Track With Its Growth Efforts: Apt to Hold?
by Zacks Equity Research
Despite cost headwinds, AB InBev's (BUD) rapid expansion of its digital platform, solid demand and continued premiumization bode well.
Molson Coors (TAP) Extends ZOA Energy Deal to Expand Beyond Beer
by Zacks Equity Research
Molson Coors (TAP) increases its investment in ZOA Energy to strengthen its beyond beer portfolio.
Hostess Brands (TWNK) to be Acquired by The J.M. Smucker
by Zacks Equity Research
The acquisition of Hostess Brands (TWNK) by The J.M. Smucker aims to capitalize on the synergy between the two well-established consumer goods companies.
The J.M. Smucker (SJM) to Buy Hostess Brands: Things to Know
by Zacks Equity Research
The J.M. Smucker (SJM) to acquire Hostess Brands (TWNK) by third-quarter fiscal 2024. The deal is priced at $34.25 per share in a cash and stock transaction.
The J.M. Smucker (SJM) to Potentially Buy Hostess Brands
by Zacks Equity Research
Per reports, The J.M. Smucker Company (SJM) will likely acquire Hostess Brands (TWNK) for nearly $5 billion.
Can Strategic Growth Efforts Aid Clorox (CLX) Amid High Costs?
by Zacks Equity Research
Despite inflation concerns, Clorox (CLX) looks well-poised to drive growth on solid demand, pricing actions, cost-saving efforts and other growth strategies.
Can Strategic Growth Endeavors Aid Newell (NWL) Amid Inflation?
by Zacks Equity Research
Despite inflationary pressures, Newell (NWL) looks promising on the back of cost-cutting initiatives and a solid online show.
Hormel Foods (HRL) Stock Dips on Q3 Earnings & Sales Miss
by Zacks Equity Research
Hormel Foods' (HRL) third-quarter fiscal 2023 results reflect weakness in the Retail and International segments. Continued momentum in the Foodservice unit acts as an upside.
Church & Dwight (CHD) Up More Than 15% YTD: Will It Stay?
by Zacks Equity Research
Constant brand investments, product innovation, effective pricing actions and successful execution are contributing to Church & Dwight's (CHD) growth.
The Estee Lauder Companies (EL) Dips More Than 35%: Here's Why
by Zacks Equity Research
The Estee Lauder Companies (EL) is cautious about economic hurdles in China, volatile inflation levels, foreign currency fluctuations and concerns surrounding the recession.
Company News for Aug 30, 2023
by Zacks Equity Research
Companies in The News Are: BBY,SJM,GOGL,BNS
Strength in Brand Portfolio Aids Kellogg (K), Rising Costs Ail
by Zacks Equity Research
Kellogg (K) is focused on investing in brand-building efforts. However, adverse impacts of high input cost inflation and shortages are a concern.
Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why
by Zacks Equity Research
Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consumer spending and customer acquisition.
10 Drugs Selected for Medicare Price Reduction
by Zacks Equity Research
10 Drugs Selected for Medicare Price Reduction
Medicare Drugs Targeted Under Inflation Reduction Act
by Mark Vickery
Last year, these 10 drugs made up $50 billion, about 20%, of Medicare part D costs.